LifeStance Health officer awarded 107,914 RSUs

LifeStance Health Group, Inc. reported that officer Lisa K. Miller received an equity grant of 107,914 restricted stock units on March 5, 2026.

Accepted by SEC EDGAR 03/09/2026 - 08:09 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group, Inc. reported that officer Lisa K. Miller received an equity grant of 107,914 restricted stock units on March 5, 2026. Each RSU represents a contingent right to receive one share of common stock.

On March 6, 2026, 21,590 shares of common stock were withheld by the company at $6.93 per share to cover tax obligations related to vested RSUs. The footnote states this was not an open-market sale but a reduction in shares issued upon settlement. After these transactions, Miller directly held 330,577 shares of common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Miller Lisa K

Role See Remarks

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	21,590	$6.93	$150K
Grant/Award	Common Stock	107,914	$0.00	$0.00

Holdings After Transaction: Common Stock — 330,577 shares (Direct)

Footnotes (2)

1. F1. Includes 107,914 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. F2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LifeStance Health (LFST) report for Lisa K. Miller?

LifeStance Health reported two transactions for officer Lisa K. Miller: a grant of 107,914 restricted stock units on March 5, 2026, and a withholding of 21,590 shares on March 6, 2026 to cover tax obligations on vested RSUs.

How many RSUs were granted to the LifeStance Health (LFST) executive?

Lisa K. Miller received 107,914 restricted stock units on March 5, 2026. Each RSU represents a contingent right to receive one share of LifeStance Health common stock, increasing her potential future equity stake if the vesting conditions are satisfied.

Were any LifeStance Health (LFST) shares sold on the open market in this Form 4?

No open-market sale occurred. The 21,590 LifeStance Health shares reported on March 6, 2026 were withheld by the issuer to satisfy tax withholding obligations on vested RSUs and are explicitly described as not constituting any open-market sale.

Why did LifeStance Health (LFST) withhold 21,590 shares from Lisa K. Miller?

LifeStance Health withheld 21,590 shares on March 6, 2026 to satisfy tax withholding obligations from the net settlement of RSUs that vested. This reduced the number of shares issued to Lisa K. Miller, rather than representing a discretionary sale in the market.

What is Lisa K. Miller’s direct LifeStance Health (LFST) share ownership after these transactions?

Following the March 5–6, 2026 transactions, Lisa K. Miller directly held 330,577 shares of LifeStance Health common stock. This figure reflects the RSU-related grant and the tax withholding share reduction disclosed in the Form 4 filing’s ownership table.

What does the RSU grant mean for LifeStance Health (LFST) executive compensation?

The 107,914 RSU grant represents equity-based compensation for Lisa K. Miller, aligning part of her pay with LifeStance Health’s stock performance. Each RSU can convert into one common share if vesting conditions are met, potentially increasing her ownership over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Lisa K

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		107,914(1)	A	$0	352,167	D
Common Stock	03/06/2026		F(2)		21,590	D	$6.93	330,577	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 107,914 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

Remarks:

Executive Vice President, Practice Operations

	By: /s/ Ryan Pardo, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.